Whole 24-hour continuous glucose monitoring profiles with insulin glargine or oral antidiabetic drug therapy in patients with type 2 diabetes mellitus

被引:0
|
作者
Yale, J. -F. [1 ]
Harris, S. [2 ]
Stewart, J. A. [3 ]
Gerstein, H. C.
机构
[1] McGill Univ, Ctr Hlth, McGill Nutr Ctr, Montreal, PQ, Canada
[2] Univ Western Ontario, London, England
[3] Sanofi Aventis, Biometr, Bridgewater, MA USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
1060
引用
收藏
页码:S431 / S431
页数:1
相关论文
共 50 条
  • [21] Ambulatory 24-hour fast using flexible insulin therapy in patients with type 1 diabetes
    Vigeral, C.
    Sola-Gazagnes, A.
    Nejjar, S.
    M'Bemba, J.
    Boitard, C.
    Slama, G.
    Elgrably, F.
    Larger, E.
    DIABETES & METABOLISM, 2011, 37 (06) : 553 - 559
  • [22] Relationships between microalbuminuria and 24-hour ambulatory blood pressure monitoring parameters in patients with type 2 diabetes mellitus
    Cardoso, C.
    Leite, N.
    Muxfeldt, E.
    Salles, G.
    JOURNAL OF HYPERTENSION, 2008, 26 : S193 - S193
  • [23] Usefulness of continuous blood glucose monitoring to assess the 24-hour pharmacodynamic profile of a sulfonyurea in type 2 diabetic patients
    Bauduceau, B
    Bailleau, C
    Charbonnel, B
    Gin, H
    Bouhanick, B
    Raccah, D
    Vaur, L
    Halimi, S
    Attali, JR
    DIABETES, 2004, 53 : A471 - A471
  • [24] Influence of Insulin-Sensitizers in Type 2 Diabetes Mellitus Patients Glargine Therapy
    Constantin, Ciprian
    Constantin, Georgiana
    Cheta, Dan
    DIABETES, 2011, 60 : A674 - A675
  • [25] Combined insulin glargine and metformin therapy for obese patients with type 2 diabetes mellitus
    Stryjek-Kaminska, D
    Plininger, I
    Jaursch-Hancke, C
    DIABETES, 2002, 51 : A423 - A424
  • [26] Efficacy and safety of insulin glargine added to ongoing therapy with multiple oral antidiabetic drugs (OADs) in patients with type 2 diabetes mellitus (T2DM)
    Raskin, P.
    Tanenberg, R. J.
    Vlajnic, A.
    Hollander, P.
    DIABETOLOGIA, 2007, 50 : S405 - S406
  • [27] Efficacy and safety of insulin glargine added to ongoing therapy with multiple oral antidiabetic drugs (OADs) in patients with type 2 diabetes mellitus (T2DM)
    Davidson, Mayer B.
    Raskin, Philip
    Tanenberg, Robert
    Vlajnic, Aleksandra
    Hollander, Priscilla
    DIABETES, 2007, 56 : A542 - A542
  • [28] Insulin Pumps and Continuous Glucose Monitoring in Pediatric Patients With Type 1 Diabetes Mellitus
    Tamborlane, William V.
    ENDOCRINE PRACTICE, 2012, 18 : 13 - 16
  • [29] Empagliflozin Improves 24-Hour Blood Pressure Profiles in Patients With Type 2 Diabetes and Hypertension
    Tikkanen, Ilkka
    Narko, Kirsi
    Zeller, Cordula
    Green, Alexandra
    Salsali, Afshin
    Broedl, Uli C.
    Woerle, Hans J.
    CIRCULATION, 2013, 128 (22)
  • [30] Comparison of glucose variability assessed by a continuous glucose-monitoring system in patients with type 2 diabetes mellitus switched from NPH insulin to insulin glargine: The COBIN2 study
    Zdarska, Denisa Janickova
    Kvapil, Milan
    Rusavy, Zdenek
    Krcma, Michal
    Broz, Jan
    Krivska, Bohumila
    Kadlecova, Pavla
    WIENER KLINISCHE WOCHENSCHRIFT, 2014, 126 (7-8) : 228 - 237